California State University - Interdisciplinary Cancer Meeting (CSU-ICM)

加州州立大学 - 跨学科癌症会议 (CSU-ICM)

• 批准号: 10066294
• 负责人: DAVID G BERMUDES
• 金额: $ 0.5万
• 依托单位: CALIFORNIA STATE UNIVERSITY NORTHRIDGE
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-08-01 至 2022-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10066294
• 关键词: Address; Advocate; American Association of Cancer Research; Basic Science; Biological Sciences; Biomedical Research; California; Cancer Biology; Cancer Center; Cancer Science; Cancer Survivor; Clinical; Collaborations; Communities; Data; Development; Discipline; Doctor of Philosophy; Early Diagnosis; Ensure; Event; Faculty; Feedback; Fostering; Funding; Geography; Grant; Institutes; Institution; Investigation; Knowledge; Lead; Learning; Life; Malignant Neoplasms; Mission; Neoplasm Metastasis; Oncology; Participant; Patients; Performance; Preparation; Research; Research Personnel; Resistance; Scientist; Seminal; Site; Survivors; System; United States National Institutes of Health; Universities; Visceral; Work; anticancer research; base; cancer type; career networking; demographics; design; falls; innovation; inter-institutional; interdisciplinary approach; interest; lectures; low socioeconomic status; medical schools; meetings; mortality; novel; posters; programs; racial disparity; socioeconomics; symposium; tumor; undergraduate student; underrepresented minority student

R13 Application Kelber, Tamae, De Bellard, Bermudes Title: The California State University – Interdisciplinary Cancer Meeting (CSU-ICM) – Targeting Mechanisms of Therapy Resistance PROJECT SUMMARY According to the most recent studies, the average mortality across all cancer types remains at over 30%. To develop transformative solutions to central problems in oncology research, we have established the biennial California State University – Interdisciplinary Cancer Meeting (CSU-ICM). This application is to support the 2020 meeting that will be held on Friday, November 6 at the California State University Northridge, Plaza del Sol Performance Hall. The theme for the 2020 CSU-ICM will be Targeting Mechanisms of Therapy Resistance. Currently, there is a need for cancer research meetings that provide an affordable and focused platform for interdisciplinary exchange between life scientists, non-life scientists and cancer experts. The first CSU-ICM meeting held in 2018 welcomed keynote speaker Dr. Joan Brugge from Harvard Medical School and involved over 150 participants from 10 CSU and 2 UC campuses in California and 1 non-California university. This funding application is based upon preliminary data that we collected from this inaugural event demonstrating diversity of participation at ethnic, discipline, geographic and institute levels. Thus, we postulate that strategic expansion of this meeting will further stimulate novel, collaborative lines of investigation that lead to transformative advances in cancer research and increase diversity in oncology research. The short talk sessions will be chaired by faculty leaders in their respective fields and designed to involve trainees from the undergraduate to postdoctoral levels - increasing the upward mobility of those traditionally underrepresented in cancer research. Involvement of a survivor-advocate will enhance the real need to ensure that even the most basic science research is grounded in clear personal need. The world-renowned keynote speakers ensure the highest quality of scientific exchange. The faculty flash-talk session will highlight ongoing cancer-related work from within the diverse CSU community. Finally, the poster session is designed to foster scientific exchange, networking opportunities and constructive feedback on work-in-progress. In summary, the CSU-ICM is designed to put into action core mission of the California State University system, which includes the advancement of scientific knowledge, learning, and discovery; the promotion of professional development; and the preparation of a diverse scientific workforce while also fulfilling an important need in the broader cancer research community.

R13应用 凯尔伯、塔梅、德·贝拉德、伯穆德斯 标题：加州州立大学-跨学科癌症会议(CSU-ICM)-靶向 治疗抵抗的机制 项目总结 根据最新的研究，所有癌症类型的平均死亡率 保持在30%以上。为肿瘤学的中心问题开发变革性的解决方案 研究，我们成立了两年一度的加州州立大学-跨学科 癌症会议(CSU-ICM)。这项申请是为了支持2020年的会议， 于11月6日星期五在加州州立大学北岭广场举行 演奏厅。2020年CSU-ICM的主题将是 治疗阻力。目前，有必要召开癌症研究会议，提供 一个负担得起的、专注于生命科学家之间跨学科交流的平台， 非生命科学家和癌症专家。欢迎2018年首次CSU-ICM会议 来自哈佛医学院的主讲人Joan Brugge博士，有150多人参加 参与者来自加州的10个CSU校区和2个加州大学校区，以及1个非加州校区 上大学。这份资金申请是基于我们从以下地点收集的初步数据 这一首届活动展示了种族、纪律、 地理和学院两级。因此，我们假设这一战略扩张 会议将进一步刺激新的、合作的调查路线，从而导致 癌症研究的变革性进展和肿瘤学研究的多样性。 简短的讲座将由各自领域的教职员工领导主持 旨在让从本科生到博士后级别的实习生参与-增加 那些传统上在癌症研究中代表性不足的人的向上流动性。 幸存者权益倡导者的参与将增强确保即使是 大多数基础科学研究都是基于明确的个人需求。举世闻名的 主旨演讲者确保最高质量的科学交流。教职员工的闪电谈话 会议将重点介绍CSU内部正在进行的与癌症相关的工作 社区。最后，海报会议旨在促进科学交流， 建立联系的机会和对正在进行的工作的建设性反馈。总而言之， CSU-ICM旨在将加州州立大学的核心使命付诸实践 系统，包括科学知识、学习和发现的进步； 促进专业发展；以及准备多样化的科学 同时还满足了更广泛的癌症研究中的重要需求 社区。